REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 132 filers reported holding REVANCE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $800,000 | +29268.6% | 250,000 | -1.3% | 0.14% | -67.1% |
| Q1 2023 | $2,724 | -98.4% | 253,400 | +704.4% | 0.43% | +3772.7% |
| Q3 2022 | $168,000 | +1580.0% | 31,500 | +176.3% | 0.01% | +1000.0% |
| Q2 2022 | $10,000 | +11.1% | 11,400 | -21.4% | 0.00% | – |
| Q4 2021 | $9,000 | -99.6% | 14,500 | -85.0% | 0.00% | -100.0% |
| Q2 2020 | $2,356,000 | +33557.1% | 96,480 | +793.3% | 0.13% | – |
| Q1 2020 | $7,000 | 0.0% | 10,800 | -57.8% | 0.00% | – |
| Q4 2019 | $7,000 | – | 25,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
| Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
| Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
| Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
| FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
| Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
| Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |